Investigators from the National Institutes of Health NIH report partial responses PR in peripheral T-cell lymphoma PTCL patients and PR in double-hit diffuse large b-cell lymphoma DH-DLBCL patients in ongoing dose-escalation trial of enitociclib in combination with venetoclax and prednisone Vincerx remains on target to report early clinical data from lead VersAptx platform compounds VIP early and VIP mid PALO...
Globe News Wire
Patent applications reinforce Dewpoint s leadership in the discovery of condensate-modifying drugs c-mods to treat diseases of high unmet needNew first-in-class composition of matter targeting TDP- condensates to correct complex ALS-associated neuronal dysfunction BOSTON Jan GLOBE NEWSWIRE -- Dewpoint Therapeutics Inc a biotechnology company that translates the novel science of condensates into breakthrough therapeutics today announced the filing of multiple...
SAN DIEGO Jan GLOBE NEWSWIRE -- Shareholder rights law firm Johnson Fistel LLP announces that a class action lawsuit has commenced on behalf of investors of Maison Solutions Inc NASDAQ MSS The class action is on behalf of shareholders who purchased or otherwise acquired Maison Solutions in or traceable to Maison Solutions October initial public offering the IPO The class...
Capital return to be conducted through synthetic share repurchase Return of up to million maximum approved by shareholders in designed to enable efficient return of cash to shareholders and enhance EPS Implementation planned to be completed in late January Venlo the Netherlands Jan GLOBE NEWSWIRE -- QIAGEN N V NYSE QGEN Frankfurt Prime Standard QIA today announced a plan to...